FIELD: medicine.
SUBSTANCE: object of the present invention is a method for predicting the risk of contracting diabetes mellitus or metabolic syndrome by a subject, where the specified subject does not have diabetes. Method includes the following steps: determining the level of pro-neurotensin 1-117 or peptides containing pro-neurotensin 1-117 using an immune assay in a sample of blood, serum or plasma taken from a specified subject, and correlating this level of pro-neurotensin 1-117 or peptides containing pro-neurotensin 1-117 with the risk of developing diabetes mellitus or metabolic syndrome, where an elevated level compared to the threshold value is prognostic for an increased risk of diabetes mellitus or metabolic syndrome.
EFFECT: method is proposed for predicting the risk of contracting diabetes mellitus and/or metabolic syndrome by a subject, or diagnosing the metabolic syndrome in a subject.
23 cl, 3 ex, 19 tbl, 3 dwg
